146 related articles for article (PubMed ID: 10651310)
1. Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator.
Yoshizaki T; Sato H; Murono S; Pagano JS; Furukawa M
Clin Exp Metastasis; 1999 Jul; 17(5):431-6. PubMed ID: 10651310
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
Lan YY; Hsiao JR; Chang KC; Chang JS; Chen CW; Lai HC; Wu SY; Yeh TH; Chang FH; Lin WH; Su IJ; Chang Y
J Virol; 2012 Jun; 86(12):6656-67. PubMed ID: 22514348
[TBL] [Abstract][Full Text] [Related]
3. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression.
Murono S; Yoshizaki T; Sato H; Takeshita H; Furukawa M; Pagano JS
Cancer Res; 2000 May; 60(9):2555-61. PubMed ID: 10811139
[TBL] [Abstract][Full Text] [Related]
4. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma.
Horikawa T; Yoshizaki T; Sheen TS; Lee SY; Furukawa M
Cancer; 2000 Aug; 89(4):715-23. PubMed ID: 10951332
[TBL] [Abstract][Full Text] [Related]
5. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1.
Yoshizaki T; Sato H; Furukawa M; Pagano JS
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3621-6. PubMed ID: 9520415
[TBL] [Abstract][Full Text] [Related]
6. [Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells].
Wang C; Deng X; Li X; Gu H; Yi W; Weng X; Xia L; Cao Y
Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):9-13. PubMed ID: 11977651
[TBL] [Abstract][Full Text] [Related]
7. [Effects of Epstein-Barr virus latent membrane protein 1(EBV-LMP1) on related factors of metastasis of nasopharyngeal carcinoma cell line CNE1].
Gou XM; Chen Y; Chen XY; Arrand JR
Ai Zheng; 2003 May; 22(5):481-5. PubMed ID: 12753707
[TBL] [Abstract][Full Text] [Related]
8. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
[TBL] [Abstract][Full Text] [Related]
9. [Study of the relation between MMP2, MMP9 and nasopharyngeal carcinoma].
Zhang X; Guo Y; Ye Q; Yang Z; Dong Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Aug; 13(8):356-8. PubMed ID: 12541362
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
[TBL] [Abstract][Full Text] [Related]
11. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma.
Kondo S; Wakisaka N; Schell MJ; Horikawa T; Sheen TS; Sato H; Furukawa M; Pagano JS; Yoshizaki T
Int J Cancer; 2005 Jun; 115(3):368-76. PubMed ID: 15688379
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus Zta upregulates matrix metalloproteinases 3 and 9 that synergistically promote cell invasion in vitro.
Lan YY; Yeh TH; Lin WH; Wu SY; Lai HC; Chang FH; Takada K; Chang Y
PLoS One; 2013; 8(2):e56121. PubMed ID: 23409137
[TBL] [Abstract][Full Text] [Related]
14. Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins.
Lu J; Chua HH; Chen SY; Chen JY; Tsai CH
Cancer Res; 2003 Jan; 63(1):256-62. PubMed ID: 12517806
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus Rta promotes invasion of bystander tumor cells through paracrine of matrix metalloproteinase 9.
Lan YY; Chang FH; Tsai JH; Chang Y
Biochem Biophys Res Commun; 2018 Sep; 503(3):2160-2166. PubMed ID: 30082032
[TBL] [Abstract][Full Text] [Related]
16. NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.
Chen CC; Liu HP; Chao M; Liang Y; Tsang NM; Huang HY; Wu CC; Chang YS
Oncogene; 2014 Jul; 33(28):3648-59. PubMed ID: 23975427
[TBL] [Abstract][Full Text] [Related]
17. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.
Quinlivan EB; Holley-Guthrie EA; Norris M; Gutsch D; Bachenheimer SL; Kenney SC
Nucleic Acids Res; 1993 Jul; 21(14):1999-2007. PubMed ID: 8393562
[TBL] [Abstract][Full Text] [Related]
18. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
Hergenhahn M; Soto U; Weninger A; Polack A; Hsu CH; Cheng AL; Rösl F
Mol Carcinog; 2002 Mar; 33(3):137-45. PubMed ID: 11870879
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9.
Sun W; Liu DB; Li WW; Zhang LL; Long GX; Wang JF; Mei Q; Hu GQ
Int J Oncol; 2014 May; 44(5):1551-60. PubMed ID: 24603891
[TBL] [Abstract][Full Text] [Related]
20. The bZip dimerization domain of the Epstein-Barr virus BZLF1 (Z) protein mediates lymphoid-specific negative regulation.
Hong Y; Holley-Guthrie E; Kenney S
Virology; 1997 Mar; 229(1):36-48. PubMed ID: 9123876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
